The National Institute for Prevention and Cardiovascular Health (NIPC), based in Croí Centre, Galway, won Best Research Paper three years in a row at the Irish Healthcare Awards with The Ireland-ASPIRE Study: A Nationally Representative Epidemiologic Study of Coronary Heart Disease Secondary Prevention to Inform Post-COVID CVD Prevention in Ireland (iASPIRE).
Representatives from NIPC collected the award at the 20th anniversary Irish Healthcare Awards on 15th November at a special ceremony in Dublin. The Irish Healthcare Awards are Ireland’s leading Awards, recognising innovation and excellence in the Irish healthcare sector.
iASPIRE was the first multi-centre, nationally-representative, in-person epidemiologic examination of secondary prevention in coronary heart disease that has been carried out in Ireland, with over 600 patients were enrolled at nine sites across the country. Conducted by Prof Bill McEvoy, Research and Medical Director, NIPC, from 2017-2019, the goal was to identify risk factors in coronary patients, describe their management through lifestyle and use of drug therapies and provide an objective assessment of clinical implementation of current scientific knowledge.
NIPC are conducting a follow-up of these iASPIRE participants in 2021 to determine vital status and lipid management 1-2 years after the baseline study interview.